260 related articles for article (PubMed ID: 12941830)
1. C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis.
Myoui A; Nishimura R; Williams PJ; Hiraga T; Tamura D; Michigami T; Mundy GR; Yoneda T
Cancer Res; 2003 Aug; 63(16):5028-33. PubMed ID: 12941830
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone-related protein and bone metastases.
Guise TA
Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of protein kinase c-Src reduces the incidence of breast cancer metastases and increases survival in mice: implications for therapy.
Rucci N; Recchia I; Angelucci A; Alamanou M; Del Fattore A; Fortunati D; Susa M; Fabbro D; Bologna M; Teti A
J Pharmacol Exp Ther; 2006 Jul; 318(1):161-72. PubMed ID: 16627750
[TBL] [Abstract][Full Text] [Related]
4. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.
Bendre MS; Gaddy-Kurten D; Mon-Foote T; Akel NS; Skinner RA; Nicholas RW; Suva LJ
Cancer Res; 2002 Oct; 62(19):5571-9. PubMed ID: 12359770
[TBL] [Abstract][Full Text] [Related]
5. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
[TBL] [Abstract][Full Text] [Related]
6. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
van der Pluijm G; Sijmons B; Vloedgraven H; Deckers M; Papapoulos S; Löwik C
J Bone Miner Res; 2001 Jun; 16(6):1077-91. PubMed ID: 11393785
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
[TBL] [Abstract][Full Text] [Related]
8. In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human breast cancer cells.
Rucci N; Ricevuto E; Ficorella C; Longo M; Perez M; Di Giacinto C; Funari A; Teti A; Migliaccio S
Bone; 2004 Apr; 34(4):697-709. PubMed ID: 15050901
[TBL] [Abstract][Full Text] [Related]
9. Human breast adenocarcinoma (MDA-231) and human lung squamous cell carcinoma (Hara) do not have the ability to cause bone resorption by themselves during the establishment of bone metastasis.
Tomita A; Kasaoka T; Inui T; Toyoshima M; Nishiyama H; Saiki H; Iguchi H; Nakajima M
Clin Exp Metastasis; 2008; 25(4):437-44. PubMed ID: 18301992
[TBL] [Abstract][Full Text] [Related]
10. Correlation between extent of osteolytic damage and metastatic burden of human breast cancer metastasis in nude mice: real-time PCR quantitation.
Tester AM; Sharp JA; Dhanesuan N; Waltham M; Thompson EW
Clin Exp Metastasis; 2002; 19(5):377-83. PubMed ID: 12198765
[TBL] [Abstract][Full Text] [Related]
11. Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer.
Yi B; Williams PJ; Niewolna M; Wang Y; Yoneda T
Cancer Res; 2002 Feb; 62(3):917-23. PubMed ID: 11830552
[TBL] [Abstract][Full Text] [Related]
12. A novel bisphosphonate minodronate (YM529) specifically inhibits osteolytic bone metastasis produced by human small-cell lung cancer cells in NK-cell depleted SCID mice.
Zhang H; Yano S; Miki T; Goto H; Kanematsu T; Muguruma H; Uehara H; Sone S
Clin Exp Metastasis; 2003; 20(2):153-9. PubMed ID: 12705636
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo.
Guise TA; Yin JJ; Thomas RJ; Dallas M; Cui Y; Gillespie MT
Bone; 2002 May; 30(5):670-6. PubMed ID: 11996903
[TBL] [Abstract][Full Text] [Related]
14. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY
PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.
Yoneda T; Sasaki A; Dunstan C; Williams PJ; Bauss F; De Clerck YA; Mundy GR
J Clin Invest; 1997 May; 99(10):2509-17. PubMed ID: 9153295
[TBL] [Abstract][Full Text] [Related]
17. Osteolytic bone metastasis in breast cancer.
Yoneda T; Sasaki A; Mundy GR
Breast Cancer Res Treat; 1994; 32(1):73-84. PubMed ID: 7819589
[TBL] [Abstract][Full Text] [Related]
18. The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.
Hiraga T; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 2001 Jun; 61(11):4418-24. PubMed ID: 11389070
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
Chirgwin JM; Guise TA
Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.
Boucharaba A; Serre CM; Grès S; Saulnier-Blache JS; Bordet JC; Guglielmi J; Clézardin P; Peyruchaud O
J Clin Invest; 2004 Dec; 114(12):1714-25. PubMed ID: 15599396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]